What is LetsGetChecked?
LetsGetChecked operates as a sophisticated medical technology platform designed to bridge the gap between individual consumers and a global network of accredited laboratories. By facilitating at-home health testing, the company empowers users to take control of their health data through a seamless, digital-first experience. Headquartered in New York, the platform has effectively disrupted traditional diagnostic pathways, offering a scalable solution that addresses the growing demand for convenient, reliable, and actionable health insights. Its market position is defined by its integration of logistics, clinical oversight, and user-centric software, which collectively streamline the diagnostic process for a diverse patient base.
How much funding has LetsGetChecked raised?
LetsGetChecked has raised a total of $263M across 4 funding rounds:
Series A
$12M
Series C
$71M
Series B
$30M
Series D
$150M
Series A (2018): $12M with participation from Optum Ventures
Series B (2020): $30M, investors not publicly disclosed
Series C (2020): $71M supported by Illumina Ventures, Optum Ventures, Deerfield, Transformation Capital, HLM Venture Partners, Angeles Investments, Qiming Venture Partners USA, and CommonFund Capital
Series D (2021): $150M featuring Casdin Capital
Key Investors in LetsGetChecked
Casdin Capital
Casdin Capital, LLC brings a deep understanding and long-term perspective to financing the next generation of life science innovation, with a specific focus on diagnostics and molecular information.
Illumina Ventures
Illumina Ventures is a leader in genomics and precision health investing, focused on building an ecosystem that translates investment into innovation to enhance human health.
Optum Ventures
Optum Ventures invests in early-stage companies that are poised to disrupt the status quo and make healthcare better for everyone.
What's next for LetsGetChecked?
With the infusion of capital from its latest strategic financing, LetsGetChecked is well-positioned to accelerate its expansion into new diagnostic categories and deepen its penetration in existing markets. The company is expected to prioritize the enhancement of its laboratory network and the integration of advanced data analytics to provide more comprehensive health monitoring. Furthermore, the strategic alignment with its current investor base suggests a focus on long-term value creation, potentially involving partnerships with broader healthcare ecosystems and insurance providers. As the firm moves beyond its current growth phase, the emphasis will likely shift toward operational efficiency and the solidification of its brand as a leader in the precision health and diagnostics space.
See full LetsGetChecked company page
